Detalhe da pesquisa
1.
Two-Year Outcomes with a Magnetically Levitated Cardiac Pump in Heart Failure.
N Engl J Med
; 378(15): 1386-1395, 2018 Apr 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29526139
2.
Two-year outcome after implantation of a full magnetically levitated left ventricular assist device: results from the ELEVATE Registry.
Eur Heart J
; 41(39): 3801-3809, 2020 10 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-33107561
3.
Concurrent valvular procedures during left ventricular assist device implantation and outcomes: A comprehensive analysis of the Multicenter Study of MagLev Technology in Patients Undergoing Mechanical Circulatory Support Therapy With HeartMate 3 trial portfolio.
J Thorac Cardiovasc Surg
; 166(6): 1684-1694.e18, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35643769
4.
Prediction of Survival After Implantation of a Fully Magnetically Levitated Left Ventricular Assist Device.
JACC Heart Fail
; 10(12): 948-959, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36456068
5.
Aspirin and left ventricular assist devices: rationale and design for the international randomized, placebo-controlled, non-inferiority ARIES HM3 trial.
Eur J Heart Fail
; 23(7): 1226-1237, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34142415
6.
Clinical hemodynamic evaluation of patients implanted with a fully magnetically levitated left ventricular assist device (HeartMate 3).
J Heart Lung Transplant
; 36(1): 28-35, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27773456
7.
Clinical trial design and rationale of the Multicenter Study of MagLev Technology in Patients Undergoing Mechanical Circulatory Support Therapy With HeartMate 3 (MOMENTUM 3) investigational device exemption clinical study protocol.
J Heart Lung Transplant
; 35(4): 528-36, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-27044532
8.
Percutaneous lead dysfunction in the HeartMate II left ventricular assist device.
Ann Thorac Surg
; 97(4): 1373-8, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24492061
9.
Neurocognitive assessments in advanced heart failure patients receiving continuous-flow left ventricular assist devices.
J Heart Lung Transplant
; 28(6): 542-9, 2009 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-19481013
10.
Low thromboembolism and pump thrombosis with the HeartMate II left ventricular assist device: analysis of outpatient anti-coagulation.
J Heart Lung Transplant
; 28(9): 881-7, 2009 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-19716039
11.
Hepatic artery infusion chemotherapy for metastatic colorectal cancer to the liver at the lahey clinic: comparison between two methods of treatment, surgical versus percutaneous catheter placement.
Am J Clin Oncol
; 27(4): 376-83, 2004 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-15289731
12.
Left ventricular assist device performance with long-term circulatory support: lessons from the REMATCH trial.
Ann Thorac Surg
; 78(6): 2123-9; discussion 2129-30, 2004 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-15561049